Home » Authors » Trista Morrison

Articles by Trista Morrison

Roche Ends 10-Year Court Fight By Acquiring BioVeris For $600M

April 5, 2007

By Trista Morrison

Syndax Gets $40M Series A To Build Cancer Combo Pipeline

April 4, 2007

By Trista Morrison

Syndax Gets $40M Series A To Build Cancer Combo Pipeline

April 4, 2007

By Trista Morrison

Roche Acquires Therapeutic Human Polyclonals For $56.5M

April 3, 2007

By Trista Morrison

Roche Acquires Therapeutic Human Polyclonals For $56.5M

April 3, 2007

By Trista Morrison

Vivus Gets Up To $180M From KV Pharma For Hot Flash Drug

April 2, 2007

By Trista Morrison

FDA Wants Another Phase III For NeoPharm's GBM Drug

March 30, 2007

By Trista Morrison

FDA Wants Another Phase III For NeoPharm's GBM Drug

March 30, 2007

By Trista Morrison

Samaritan, Pharmaplaz Partner On Phase II HIV Drug SP-01A

March 29, 2007

By Trista Morrison

Samaritan, Pharmaplaz Partner On Phase II HIV Drug SP-01A

March 29, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...